TWINLAB CORP
S-8, 1999-09-17
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: GEOLOGISTICS CORP, 8-K, 1999-09-17
Next: COX RADIO INC, 8-K, 1999-09-17



As filed with the Securities and Exchange Commission on September 17, 1999
                                                       Registration No. 333-
================================================================================
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                 ---------------
                                    FORM S-8
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933
                                 ---------------
                               TWINLAB CORPORATION
             (Exact name of registrant as specified in its charter)
        Delaware                                           11-3317986
  (State or Other Jurisdiction of                        (I.R.S. Employer
   Incorporation or Organization)                      Identification Number)
                                150 Motor Parkway
                            Hauppauge, New York 11788
                    (Address of Principal Executive Offices)
                                 ---------------
                         TWINLAB CORPORATION 1999 STOCK
                      INCENTIVE PLAN FOR OUTSIDE DIRECTORS
                            (Full Title of the Plan)
                              Philip M. Kazin, Esq.
                     Chief Legal Officer and General Counsel
                               Twinlab Corporation
                                150 Motor Parkway
                            Hauppauge, New York 11788
                     (Name and Address of Agent for Service)

                                 (516) 467-3140
                     (Telephone Number, Including Area Code,
                              of Agent for Service)

                                   Copies to:

                              Howard A. Sobel, Esq.
                       Kramer Levin Naftalis & Frankel LLP
                                919 Third Avenue
                            New York, New York 10022
                                 (212) 715-9100

In addition,  pursuant to Rule 416(c)  under the  Securities  Act of 1933,  this
registration  statement also covers an  indeterminate  amount of interests to be
offered or sold pursuant to the employee benefit plan described herein.
                         CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
===================================================================================================================================
                                                           Proposed                   Proposed
                                                           Maximum                    Maximum
Title of                                                   Offering                   Aggregate                  Amount of
Securities to                Amount to be                  Price Per                  Offering                   Registration
be Registered                Registered                    Share                      Price                      Fee
- -----------------------------------------------------------------------------------------------------------------------------------
<S>                          <C>                           <C>                        <C>                        <C>
Common                       6,184                         $ 8.624(2)                 $ 53,331                   $ 14.83
Stock (par                   shares(1)
value $1.00                                                $ 7.3125(3)                $ 430,092                  $ 119.57
per share)                   58,816 shares
===================================================================================================================================
</TABLE>
(1)  Representing  shares  which were  issued  pursuant  to the Plan on June 18,
     1999.
(2)  The last sale price per share on June 18, 1999.
(3)  Estimated, in accordance with 17 CFR 230.457(c),  solely for the purpose of
     calculating the  registration  fee. The Proposed Maximum Offering Price Per
     Share is based on the  average  of the high and low  prices  for the Common
     Stock reported by the Nasdaq  National Market of The Nasdaq Stock Market on
     September  13, 1999,  which is within five (5)  business  days prior to the
     date of this Registration Statement.
<PAGE>

                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

         The Registrant  hereby  incorporates by reference in this  Registration
Statement the following documents:

         (1) The Company's  Annual Report on Form 10-K for the fiscal year ended
December  31,  1998,  filed  March 31,  1999  pursuant  to Section  13(a) of the
Securities Exchange Act of 1934, as amended (the "1934 Act");

         (2) The Company's  Annual Report on Form  10-K405/A for the fiscal year
ended  December 31, 1998,  filed April 30, 1999 pursuant to Section 13(a) of the
1934 Act;

         (3) The Company's  Quarterly Report on Form 10-Q for the fiscal quarter
ended March 31, 1999,  filed May 12, 1999  pursuant to Section 13(a) of the 1934
Act;

         (4) The Company's  Quarterly Report on Form 10-Q for the fiscal quarter
ended June 30, 1999, filed August 13, 1999 pursuant to Section 13(a) of the 1934
Act;

         (5) The  Company's  Quarterly  Report  on Form  10-Q/A  for the  fiscal
quarter ended March 31, 1998,  filed March 30, 1999 pursuant to Section 13(a) of
the 1934 Act;

         (6) The  Company's  Quarterly  Report  on Form  10-Q/A  for the  fiscal
quarter  ended June 30, 1998,  filed March 30, 1999 pursuant to Section 13(a) of
the 1934 Act;

         (7) The  Company's  Quarterly  Report  on Form  10-Q/A  for the  fiscal
quarter ended September 30, 1998, filed March 30, 1999 pursuant to Section 13(a)
of the 1934 Act;

         (8) The Company's Registration Statement on Form 8-A, filed pursuant to
Section 12(g) of the Exchange Act, which contains a description of the Company's
Common  Stock,  including  any  amendment  or report  filed for the  purpose  of
updating such description; and

         (9) All  documents  subsequently  filed  by the  Company  with  the SEC
pursuant to Sections  13(a),  13(c),  14 or 15(d) of the 1934 Act,  prior to the
filing  of a  post-effective  amendment  to  the  Registration  Statement  which
indicates that all securities offered hereby have been sold or which deregisters
all securities  then remaining  unsold,  shall be deemed to be  incorporated  by
reference in this  Registration  Statement and to be a part hereof from the date
of filing of such documents.

Item 4.   Description of Securities.

         Not applicable.

Item 5.   Interest of Named Experts and Counsel.

         Not applicable.

Item 6.   Indemnification of Directors and Officers.

         Reference  is  made  to  Section  102(b)(7)  of  the  Delaware  General
Corporation Law (the "DGCL"),  which permits a corporation in its certificate of
incorporation or an amendment thereto to eliminate or limit the personal


                                      -3-
<PAGE>

liability of a director for violations of the director's  fiduciary duty, except
(i)  for  any  breach  of  the  director's  fiduciary  duty  of  loyalty  to the
corporation or its stockholders, (ii) for acts or omissions not in good faith or
which  involve  intentional  misconduct  or a knowing  violation  of law,  (iii)
pursuant to Section 174 of the DGCL  (providing  for  liability of directors for
unlawful  payment of dividends or unlawful stock purchases or  redemptions),  or
(iv) for any transaction  from which the director  derived an improper  personal
benefit.   The   Registrant's   Second  Amended  and  Restated   Certificate  of
Incorporation contains provisions permitted by Section 102(b)(7) of the DGCL.

         Reference  is made to  Section  145 of the DGCL which  provides  that a
corporation  may indemnify any persons,  including  directors and officers,  who
are,  or are  threatened  to be made,  parties  to any  threatened,  pending  or
completed   legal  action,   suit  or  proceeding,   whether  civil,   criminal,
administrative or investigative (other than an action by or in the right of such
corporation),  by  reason of the fact  that  such  person is or was a  director,
officer,  employee  or agent of such  corporation,  or is or was  serving at the
request of such corporation as a director, officer, employee or agent of another
corporation  or  enterprise.  The  indemnity  may  include  expenses  (including
attorneys' fees),  judgments,  fines and amounts paid in settlement actually and
reasonably  incurred  by such person in  connection  with such  action,  suit or
proceeding,  provided such  director,  officer,  employee or agent acted in good
faith and in a manner he  reasonably  believed  to be in or not  opposed  to the
corporation's  best  interests  and,  with  respect  to any  criminal  action or
proceedings, had no reasonable cause to believe that his conduct was unlawful. A
Delaware  corporation  may indemnify  directors  and/or officers in an action or
suit by or in the right of the  corporation  under the same  conditions,  except
that no  indemnification  is permitted without judicial approval if the director
or officer is  adjudged  to be liable to the  corporation.  Where a director  or
officer is  successful  on the merits or  otherwise in the defense of any action
referred  to above,  the  corporation  must  indemnify  him or her  against  the
expenses which such director or officer actually and reasonably incurred.

         The   Registrant's   Second   Amended  and  Restated   Certificate   of
Incorporation  and Amended and Restated By-laws provide for the  indemnification
of directors and officers of the Registrant to the fullest  extent  permitted by
the DGCL.

         The  Registrant  maintains  liability  insurance  for each director and
officer for certain  losses  arising  from claims or charges  made  against them
while acting in their capacities as directors or officers of the Registrant.

         Section 4 of the Plan provides that the Registrant shall indemnify each
member of the  Committee  and any other  director  or employee of the Company to
whom any duty or power relating to the  administration  or interpretation of the
Plan has been  delegated  against  any  costs or  expenses  arising  out of such
activities, except where the individual acted in bad faith or without reasonable
belief that it was in the best interests of the Company.

Item 7.   Exemption from Registration Claimed.

         Not applicable.

Item 8.    Exhibits.

            Exhibit Number   Description
            --------------   -----------

               4.1            Second   Amended  and  Restated   Certificate   of
                              Incorporation   of  the  Registrant,   as  amended
                              (incorporated  by  reference  to  Exhibit  3.4  to
                              Amendment No. 1 to the  Registration  Statement on
                              Form S-4, dated September 18, 1996,  filed by Twin
                              Laboratories Inc., Registration No. 333-6781).

               4.2            Amended  and  Restated  By-laws of the  Registrant
                              (incorporated  by  reference  to  Exhibit  3.5  to
                              Amendment No. 1 to the Registration


                                      -4-
<PAGE>

                              Statement on Form S-4,  dated  September 18, 1996,
                              filed by Twin Laboratories Inc.,  Registration No.
                              333-6781).

               4.3            Form of Option Agreement.

               4.4            Form of Restricted Stock Grant Agreement.

               5              Opinion of Kramer  Levin  Naftalis  & Frankel  LLP
                              regarding  legality of securities being registered
                              (including consent).

               23.1           Consent of Independent Auditors.

               23.2           Consent of Kramer  Levin  Naftalis  & Frankel  LLP
                              (contained  in the  Opinion  filed  as  Exhibit  5
                              hereto).

Item 9.    Undertakings.

             The undersigned Registrant hereby undertakes:

             (1) To file,  during any period in which  offers or sales are being
made, a post-effective  amendment to this Registration  Statement to include any
material  information  with respect to the plan of  distribution  not previously
disclosed  in  the  Registration  Statement  or  any  material  change  to  such
information in the Registration Statement.

             (2) That,  for the purpose of determining  any liability  under the
Securities Act, each such  post-effective  amendment shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities  at the time shall be deemed to be the initial bona
fide offering thereof.

             (3)  To  remove  from   registration  by  means  of  post-effective
amendment  any of the  securities  being  registered  which remain unsold at the
termination of the offering.

             The undersigned  Registrant hereby undertakes that, for purposes of
determining  any  liability  under  the  Securities  Act,  each  filing  of  the
Registrant's  annual  report  pursuant to Section  13(a) or Section 15(d) of the
Exchange Act (and, where  applicable,  each filing of an employee benefit plan's
annual  report   pursuant  to  Section  15(d)  of  the  Exchange  Act)  that  is
incorporated by reference in the Registration  Statement shall be deemed to be a
new registration  statement relating to the securities offered therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

             Insofar  as  indemnification  for  liabilities  arising  under  the
Securities Act may be permitted to directors,  officers and controlling  persons
of the  Registrant  pursuant to the  foregoing  provisions,  or  otherwise,  the
Registrant  has been advised that in the opinion of the  Securities and Exchange
Commission  such  indemnification  is against  public policy as expressed in the
Securities Act and is, therefore,  unenforceable.  In the event that a claim for
indemnification  against  such  liabilities  (other  than  the  payment  by  the
Registrant of expenses  incurred or paid by a director,  officer or  controlling
person of the  Registrant  in the  successful  defense  of any  action,  suit or
proceeding)  is  asserted by such  director,  officer or  controlling  person in
connection with the securities being registered,  the Registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit  to a  court  of  appropriate  jurisdiction  the  question  whether  such
indemnification  by it is against  public policy as expressed in the  Securities
Act and will be governed by the final adjudication of such issue.

                                      -5-
<PAGE>

                                   SIGNATURES

             Pursuant to the  requirements  of the  Securities  Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized,  in the City of  Hauppauge,  State of New York,  on this 17th day of
September, 1999.

                                 TWINLAB CORPORATION

                                 By: /s/   Ross Blechman
                                    ----------------------------------------
                                    Name:  Ross Blechman
                                    Title: Chairman of the Board, Chief
                                           Executive Officer and President

             Pursuant to the  requirements  of the Securities Act of 1933,  this
Registration  Statement  has  been  signed  by  the  following  persons  in  the
capacities and on the dates indicated.

       Signature                 Title(s)                         Date
       ---------                 --------                         ----
/s/ Ross Blechman
- ------------------------   Chairman of the Board, President   September 17, 1999
Ross Blechman              and Chief Executive Officer

/s/ Neil Blechman
- ------------------------   Executive Vice President,          September 17, 1999
Neil Blechman              Secretary and Director

/s/ Brian Blechman
- ------------------------   Executive Vice President,          September 17, 1999
Brian Blechman             Treasurer and Director

/s/ Steve Blechman
- ------------------------   Executive Vice President and       September 17, 1999
Steve Blechman             Director

/s/ Dean Blechman
- ------------------------   Executive Vice President and       September 17, 1999
Dean Blechman              Director

/s/ Stephen L. Welling
- ------------------------   President, Health and Natural      September 17, 1999
Stephen L. Welling         Food Store Division, and
                           Director

/s/ Jonathan D. Sokoloff
- ------------------------
Jonathan D. Sokoloff       Director                           September 17, 1999

/s/ John G. Danhakl
- ------------------------
John G. Danhakl            Director                           September 17, 1999

/s/ William U. Westerfield
- ------------------------
William U. Westerfield     Director                           September 17, 1999

/s/ Robert S. Apatoff
- ------------------------
Robert S. Apatoff          Director                           September 17, 1999

                Pursuant to the  requirements of the Securities Act of 1933, the
trustees (or other persons who administer  the employee  benefit plan) have duly
caused  this  registration   statement  to  be  signed  on  its  behalf  by  the
undersigned,  thereunto duly authorized, in the City of Hauppauge,  State of New
York, on September 17, 1999.

<PAGE>

                              Twinlab Corporation 1999 Stock Incentive Plan for
                                Outside Directors

                                By: /s/ Ross Blechman
                                   ------------------
                                    Name: Ross Blechman
                                    Title: Chairman of the Board,
                                           President and Chief Executive Officer

<PAGE>

                                  EXHIBIT INDEX

    Exhibit Number                   Description
    --------------                   -----------

         4.1              Second     Amended    and     Restated
                          Certificate  of  Incorporation  of the
                          Registrant,  as amended  (incorporated
                          by   reference   to  Exhibit   3.4  to
                          Amendment  No.  1 to the  Registration
                          Statement on Form S-4, dated September
                          18, 1996,  filed by Twin  Laboratories
                          Inc., Registration No.
                          333-6781).

         4.2              Amended  and  Restated  By-laws of the
                          Registrant  (incorporated by reference
                          to Exhibit 3.5 to  Amendment  No. 1 to
                          the  Registration  Statement  on  Form
                          S-4, dated  September 18, 1996,  filed
                          by     Twin     Laboratories     Inc.,
                          Registration No. 333-6781).

         4.3              Form of Option Agreement.

         4.4              Form of Restricted Stock Grant Agreement.

         5                Opinion  of Kramer  Levin  Naftalis  &
                          Frankel  LLP  regarding   legality  of
                          securities being registered (including
                          consent).

         23.1             Consent of Independent Auditors.

         23.2             Consent of Kramer Levin Naftalis & Frankel LLP
                          (contained in the Opinion filed as Exhibit 5 hereto).





                                                                     Exhibit 4.3


                               TWINLAB CORPORATION
               NON-EMPLOYEE DIRECTOR STOCK OPTION GRANT AGREEMENT


                  THIS  AGREEMENT,  made as of this  ____  day of  ____,  ______
between   TWINLAB   CORPORATION   (the   "Company")  and   ______________   (the
"Participant").

                  WHEREAS,  the Company has  adopted and  maintains  the Twinlab
Corporation  1999 Stock  Incentive  Plan for Outside  Directors  (the "Plan") to
promote the  interests  of the Company and its  shareholders  by  providing  the
Company's  non-employee  directors  with  appropriate  incentives and rewards to
encourage them to take a long-term outlook when formulating policy applicable to
the Company,  to provide incentives for qualified  individuals to become members
of the Board of Directors,  to encourage such individuals to remain on the Board
of Directors and to provide them with an equity interest in the Company;

                  WHEREAS, the Plan provides that the Compensation  Committee of
the Board of Directors (the "Committee") shall administer the Plan;

                  WHEREAS,  the Plan provides that as of the date following each
annual  meeting of the  Company  each  Participant  shall be granted  options to
purchase  2,500 shares of the common  stock of the Company,  par value $1.00 per
share ("Stock"); and

                  WHEREAS, the Company's annual meeting for 1999 was held on
__________________________;

                  NOW,  THEREFORE,  in  consideration  of the  premises  and the
mutual  covenants  hereinafter  set forth,  the parties  hereto  hereby agree as
follows.

                  1. Grant of Option. Pursuant to, and subject to, the terms and
conditions set forth herein and in the Plan, the Committee  hereby grants to the
Participant  an option (the  "Option") to purchase  2,500  shares of Stock.  The
Option does not  constitute  an "incentive  stock option"  within the meaning of
Section 422 of the Internal Revenue Code of 1986.

                  2. Grant  Date.  The Grant Date of the Option is  _________,
_____.

                  3.   Incorporation   of  Plan.   All  terms,   conditions  and
restrictions  of the Plan are  incorporated  herein  and made part  hereof as if
stated herein.  If there is any conflict between the terms and conditions of the
Plan or this Agreement,  the terms and conditions of the Plan, as interpreted by
the  Committee,   shall  govern.   Except  as  otherwise  provided  herein,  all
capitalized  terms used herein shall have the meaning given to such terms in the
Plan.

<PAGE>

                  4.  Vesting Date.  THE OPTION SHALL FIRST BECOME EXERCISABLE
WITH RESPECT TO THE FOLLOWING NUMBER OF SHARES ON THE FOLLOWING
DATES:

==========================================================================
     Number of Shares                First Date on Which Such Number of
                                         Shares Becomes Exercisable
==========================================================================
            833
- --------------------------------------------------------------------------
            833
- --------------------------------------------------------------------------
            834
==========================================================================


                  5. Exercise Price. The exercise  price-per share of each share
with respect to which the Option is granted is $______, the Fair Market Value of
Stock on the Grant Date.

                  6. Expiration Date; Effect of Termination of Membership on the
Board of Directors.

                  (a) Subject to the provisions of the Plan and this  Agreement,
the Option granted hereby shall expire and terminate on the tenth anniversary of
the Grant Date.

                  (b) In the event that a Participant's  membership on the Board
of  Directors  terminates  for any reason  other than the  Participant's  death,
disability or the termination for Cause of the  Participant's  membership on the
Board of Directors, (i) the Option, to the extent that it was exercisable at the
time of such  termination,  shall remain  exercisable until the expiration of 90
days after such termination, on which date it shall expire, and (ii) the Option,
to the extent that it was not exercisable at the time of such termination, shall
expire  at the  close of  business  on the date of such  termination;  provided,
however,  that the Option shall not be  exercisable  after the expiration of its
term.

                  (c) In the event that (A) a  Participant's  membership  on the
Board of Directors  terminates because of the Participant's  disability or death
or (B) a Participant  dies during the 90-day period under Section 6(b),  (i) the
Option, to the extent that it was exercisable at the time of such termination or
death,  shall remain  exercisable  until the  expiration  of one year after such
termination or death, on which date it shall expire, and (ii) the Option, to the
extent that it was not  exercisable  at the time of such  termination  or death,
shall expire at the close of business on the date of such  termination or death;
provided, however, that the Option shall not be exercisable after the expiration
of its term.

                  (d) In the event that a Participant's  membership on the Board
of  Directors  is  terminated  for  Cause,   the  Option  shall  expire  at  the
commencement  of  business  on the date of such  termination.  In the  event the
Participant  has been permitted to exercise the Option,  in whole or in part, on
or after the date the  Participant's  membership  on the Board of  Directors  is
deemed to have been terminated for Cause,  such exercise shall be deemed to have
been

                                        2

<PAGE>

void ab initio and, upon demand by the Company,  the Participant shall return to
the Company  any shares  purchased  upon such  exercise,  and the Company  shall
return to the Participant the exercise price paid by the Participant.

                  (e) In the event that a Participant's  membership on the Board
of  Directors  is  terminated  for Cause  within  one year  after the  Option is
exercised,  in whole or in part,  all gain (as such term is defined in Section 8
of the Plan) realized by the Participant from such exercise shall be paid to the
Company by the Participant upon notice from the Company to the Participant.

           7.  Method of Exercise.

           (a) The Option shall be  exercisable  in whole or in part;  provided,
however,  that no  partial  exercise  of the  Option  shall be for an  aggregate
exercise price of less than $1,000. The partial exercise of the Option shall not
cause the  expiration,  termination  or  cancellation  of the remaining  portion
thereof.  Upon the  partial  exercise  of the Option,  this  Agreement  shall be
returned to the  Participant  together  with the  delivery  of the  certificates
described in Section 7(d).

           (b) The  Option  shall  be  exercised  by  delivering  notice  to the
Company's principal office, to the attention of its Secretary,  no less than one
business day in advance of the  effective  date of the proposed  exercise.  Such
notice  shall be  accompanied  by this  Agreement,  shall  specify the number of
shares of Stock  with  respect to which the  Option is being  exercised  and the
effective date of the proposed  exercise and shall be signed by the Participant.
The  Participant  may  withdraw  such  notice at any time  prior to the close of
business on the business day  immediately  preceding the  effective  date of the
proposed exercise, in which case this Agreement shall be returned to him.

           (c) Payment for shares of Stock  purchased  upon the  exercise of the
Option shall be made on the effective date of such exercise  either (A) in cash,
by certified check,  bank cashier's check or wire transfer or (B) subject to the
approval of the Board of Directors,  in shares of Stock owned by the Participant
and valued at their Fair Market Value on the effective date of such exercise, or
partly in shares of Stock with the balance in cash,  by  certified  check,  bank
cashier's  check or wire  transfer.  Any  payment  in shares  of Stock  shall be
effected by the delivery of such shares to the  Secretary  of the Company,  duly
endorsed  in blank or  accompanied  by stock  powers  duly  executed  in  blank,
together with any other  documents and evidences as the Secretary of the Company
shall require from time to time.

           (d)  Certificates  for shares of Stock purchased upon the exercise of
the Option shall be issued in the name of the  Participant,  his  beneficiary or
such other  party to whom the  Participant  transferred  the Option  pursuant to
Section 9, below,  as the case may be, and  delivered  to the  Participant,  his
beneficiary  or such  other  party,  as the case may be, as soon as  practicable
following the effective date of such exercise.

                                        3

<PAGE>

           8.  Securities Matters.

                  (b) The Company shall be under no obligation to (i) effect the
registration pursuant to the Securities Act of 1933 of any interests in the Plan
or any shares of Stock to be issued  thereunder or to effect similar  compliance
under  any  state  laws;  or  (ii)  to  cause  to be  issued  or  delivered  any
certificates  evidencing  shares of Stock  pursuant  hereto unless and until the
Company  is  advised by its  counsel  that the  issuance  and  delivery  of such
certificates  is  in  compliance  with  all  applicable  laws,   regulations  of
governmental  authority and the requirements of any securities exchange on which
shares of Stock are traded.  The  Committee  may require,  as a condition of the
issuance and delivery of certificates evidencing shares of Stock pursuant to the
terms hereof, that the recipient of such shares make such covenants,  agreements
and  representations,  and that  such  certificates  bear such  legends,  as the
Committee, in its sole discretion, deems necessary or desirable. The Participant
specifically understands and agrees that the shares of Stock, if and when issued
upon exercise of the Option,  may be  "restricted  securities,"  as that term is
defined  in Rule 144 under the  Securities  Act of 1933  and,  accordingly,  the
Participant  may be  required  to hold the shares  indefinitely  unless they are
registered under such Act or an exemption from such registration is available.

                  (b) The exercise of the Option shall be effective only at such
time as counsel to the  Company  shall have  determined  that the  issuance  and
delivery of shares of Stock pursuant to such exercise is in compliance  with all
applicable laws,  regulations of governmental  authority and the requirements of
any securities  exchange on which shares of Stock are traded. The Committee may,
in its sole discretion, defer the effectiveness of any exercise of the Option in
order to allow  the  issuance  of shares of Stock  pursuant  thereto  to be made
pursuant to registration or an exemption from  registration or other methods for
compliance available under federal or state securities laws. The Committee shall
inform the Participant in writing of its decision to defer the  effectiveness of
the  exercise of the Option.  During the period  that the  effectiveness  of the
exercise  of the Option  has been  deferred,  the  Participant  may,  by written
notice,  withdraw  such  exercise  and obtain the refund of any amount paid with
respect thereto.

                                        4

<PAGE>

                  9.  Transferability.  The Option shall be exercisable  only by
the Participant  and shall not be assignable or transferable  otherwise than (i)
to the  Participant's  spouse,  children  or  grandchildren  ("Immediate  Family
Members"), (ii) to a trust or trusts for the exclusive benefit of such Immediate
Family  Members,  (iii)  to  other  parties  as the  Committee  in its  absolute
discretion may from time to time approve, or (iv) by will or the laws of descent
and distribution.  Following any such transfer,  the Option shall continue to be
subject to the same terms and conditions as were applicable immediately prior to
the transfer.  If the Participant is incapacitated,  the Option may be exercised
on  the   Participant's   behalf  by  the   Participant's   guardian   or  legal
representative,  provided, however, that such an exercise shall not be effective
unless and until the Committee has received  evidence  satisfactory  to it as to
the authority of such guardian or legal representative.

                  10.  Notices.  Any  notice  that  either  party  hereto or the
Committee  may be required or permitted to give to the other with respect to the
Plan or this Agreement shall be in writing,  and may be delivered  personally or
by mail, postage prepaid, addressed as follows:

         (a)  if to the Company:

                  Twinlab Corporation
                  150 Motor Parkway
                  Hauppauge, New York 11788
                  Attn:  [                 ]

         (b)  if to the Committee:

                  Compensation Committee of the Board of Directors
                  Twinlab Corporation
                  150 Motor Parkway
                  Hauppauge, New York 11788
                  Attn:  [Secretary]

         (c)  if to the Participant:

                  [Participant]
                  [Home address]

or to such other address as the person to whom the notice is directed shall have
designated in writing to others.

                  11. Delays or Omissions.  No delay or omission to exercise any
right,  power or remedy  accruing  to either  party  hereto  upon any  breach or
default of either party under this Agreement, shall impair any such right, power
or remedy of such party,  nor shall it be  construed  to be a waiver of any such
breach or default, or an acquiescence therein, or of or in any similar breach or
default thereafter occurring,

                                        5

<PAGE>

nor shall any waiver of any  single  breach or default be deemed a waiver of any
other breach or default theretofore or thereafter occurring. Any waiver, permit,
consent or approval of any kind or  character on the part of either party of any
breach or  default  under  this  Agreement,  or any waiver on the part of either
party of any  provisions or conditions of this  Agreement,  must be in a writing
signed by such party and shall be effective only to the extent  specifically set
forth in such writing.

                  12.  Integration.  This  Agreement,  and the  other  documents
referred  to herein or  delivered  pursuant  hereto  which  form a part  hereof,
contain  the entire  understanding  of the parties  with  respect to its subject
matter.  There  are  no  restrictions,  agreements,  promises,  representations,
warranties,  covenants or undertakings with respect to the subject matter hereof
other than those expressly set forth herein. This Agreement,  including, without
limitation, the Plan, supersedes all prior agreements and understandings between
the parties with respect to its subject matter.

                  13.  Counterparts.  This  Agreement  may be executed in two or
more counterparts,  each of which shall be deemed an original,  but all of which
shall constitute one and the same instrument.

                  14.  Governing  Law. This  Agreement  shall be governed by and
construed  and  enforced in  accordance  with the laws of the State of New York,
without regard to the provisions governing conflict of laws.

                  15.   Participant   Acknowledgment.   The  Participant  hereby
acknowledges  receipt of a copy of the Plan. The Participant hereby acknowledges
that all  decisions,  determinations  and  interpretations  of the  Committee in
respect  of the  Plan,  this  Agreement  and  the  Option  shall  be  final  and
conclusive.

                  IN WITNESS  WHEREOF,  the Company has caused this Agreement to
be duly  executed  by its  duly  authorized  officer,  and the  Participant  has
hereunto signed this Agreement on his own behalf,  thereby  representing that he
has carefully read and understands this Agreement and the Plan as of the day and
year first written above.

                               TWINLAB CORPORATION

                               By: __________________________________________

                               ______________________________________________
                               [Participant]

                                        6





                                                                     Exhibit 4.4


                               TWINLAB CORPORATION
             NON-EMPLOYEE DIRECTOR RESTRICTED STOCK GRANT AGREEMENT


                This  Agreement,  dated  this  ____  day  of ,  between  TWINLAB
CORPORATION (the "Company") and _______________ (the "Participant").

                WHEREAS,  the  Company has  adopted  and  maintains  the Twinlab
Corporation  1999 Stock  Incentive  Plan for Outside  Directors  (the "Plan") to
promote the  interests  of the Company and its  shareholders  by  providing  the
Company's  non-employee  directors  with  appropriate  incentives and rewards to
encourage them to take a long-term outlook when formulating policy applicable to
the Company,  to provide incentives for qualified  individuals to become members
of the Board of Directors,  to encourage such individuals to remain on the Board
of Directors and to provide them with an equity interest in the Company;

                WHEREAS,  the Plan provides that the  Compensation  Committee of
the Board of Directors (the "Committee") shall administer the Plan;

                WHEREAS,  the Plan provides that as of the date  following  each
annual  meeting of the Company  each  Participant  shall be granted an amount of
restricted shares of the common stock of the Company,  par value $1.00 per share
("Restricted Stock") with an aggregate value, based on the Fair Market Value for
the five trading days  preceding the Grant Date, as close to $5,000 as possible;
and

                WHEREAS, the Company's annual meeting for _____ was held on
____________;

                NOW, THEREFORE,  in consideration of the premises and the mutual
covenants hereinafter set forth, the parties hereto hereby agree as follows:

                1. Grant of Restricted  Stock.  Pursuant to, and subject to, the
restrictions, terms and conditions set forth herein and in the Plan, the Company
hereby grants to the Participant 592 shares of Restricted Stock (the "Grant").

                2. Grant Date. The Grant Date of the Grant is _______________.

                3. Incorporation of Plan. All terms, conditions and restrictions
of the Plan are incorporated herein and made part hereof as if stated herein. If
there is any  conflict  between  the  terms and  conditions  of the Plan or this
Agreement,  the  terms  and  conditions  of  the  Plan,  as  interpreted  by the
Committee,  shall govern.  Except as otherwise  provided herein, all capitalized
terms used herein shall have the meaning given to such terms in the Plan.

<PAGE>

                4.  Vesting Date.  THE GRANT SHALL VEST AND BECOME FREE OF
RESTRICTIONS WITH RESPECT TO THE FOLLOWING NUMBER OF SHARES ON
THE FOLLOWING DATES:

============================================================================
         Number of Shares                     Date on Which Such Number
                                             of Shares Vests And Becomes
                                                Free of Restrictions
============================================================================

- ----------------------------------------------------------------------------

- ----------------------------------------------------------------------------

============================================================================

                5. Restrictions on Transferability.  Until a share of Restricted
Stock vests, the Participant shall not transfer the Participant's rights to such
share of Restricted  Stock or to any rights  related  thereto.  Until a share of
Restricted Stock vests, no attempt to transfer such shares or any rights related
thereto,  whether by transfer,  pledge,  hypothecation  or otherwise and whether
voluntary  or  involuntary,  by operation  of law or  otherwise,  shall vest the
transferee  with  any  interest  or right in or with  respect  to such  share of
Restricted Stock or such related rights,  but immediately upon any such attempt,
the portion of the Grant  represented by such share of Restricted  Stock and any
related rights shall be forfeited by the Participant,  and the transfer shall be
of no force or effect.

                6.  Effect  of   Termination  of  Membership  on  the  Board  of
Directors.

                (a) In the event that the Participant's  membership on the Board
of Directors terminates for any reason, all shares of Restricted Stock that have
not vested as of the date of such termination shall be forfeited.

                (b) In the event that a Participant's membership on the Board of
Directors is terminated for Cause within one year after any portion of the Grant
vests,  all gain (as such term is defined in Section 8 of the Plan)  realized by
the  Participant  from  such  vesting  shall  be  paid  to  the  Company  by the
Participant upon notice from the Company to the Participant.

                7.  Issuance of Certificates.

                (a)  Reasonably  promptly after the Grant Date for any shares of
Restricted  Stock that have not theretofore  been  forfeited,  provided that the
Company has  received a stock power  endorsed by the  Participant  in blank with
respect to such  shares of  Restricted  Stock,  the  Company  shall  issue stock
certificates,  registered in the name of the Participant, evidencing such shares
of Restricted Stock. Each such certificate shall bear the following legend:

                                        2

<PAGE>

                         "The transferability of this certificate and the shares
                of stock  represented  hereby are  subject to the  restrictions,
                terms  and  conditions   (including  forfeiture  provisions  and
                restrictions   against   transfer)   contained  in  the  Twinlab
                Corporation 1999 Stock Incentive Plan for Outside  Directors and
                an Agreement  entered into between the registered  owner of such
                shares and Twinlab Corporation. A copy of the Plan and Agreement
                is  on  file  in  the  office  of  the   Secretary   of  Twinlab
                Corporation, 150 Motor Parkway, Hauppauge, New York 11788."

Such legend shall not be removed from the certificates evidencing such shares of
Restricted Stock until such shares vest.

                (b) Each  certificate  issued  pursuant to Section  7(a) hereof,
together  with the stock  powers  relating to such shares of  Restricted  Stock,
shall be deposited by the Company  with a custodian  designated  by the Company.
The Company may designate itself as custodian hereunder. The Company shall cause
such custodian to issue to the Participant a receipt evidencing the certificates
held by it which are registered in the name of the Participant.

                (c)  Reasonably  promptly  after any such  shares of  Restricted
Stock vest  pursuant to Section 4 hereof,  the Company  shall cause to be issued
certificates  evidencing  such shares of  Restricted  Stock,  free of the legend
provided  in  Section  7(a)  hereof  and shall  cause  such  certificates  to be
delivered  to the  Participant  (or  such  Participant's  legal  representative,
beneficiary or heir),  together with any other property of the Participant  held
by the custodian pursuant to Section 10 hereof.

                (d) The  Participant  shall not be deemed for any purpose to be,
or have rights as, a shareholder  of the Company by virtue of the Grant,  except
to the extent a stock  certificate is issued  therefor  pursuant to Section 7(a)
hereof, and then only from the date such certificate is issued.

                8. Securities  Matters.  Notwithstanding  anything herein to the
contrary,   the  Company  shall  be  under  no  obligation  (i)  to  effect  the
registration  pursuant to the Securities Act of 1933 of any shares of Restricted
Stock to be issued  hereunder or to effect  similar  compliance  under any state
laws;  or (ii) to cause to be issued or delivered  any  certificates  evidencing
shares of  Restricted  Stock  awarded  by this  Agreement  unless  and until the
Company  is  advised by its  counsel  that the  issuance  and  delivery  of such
certificates  is  in  compliance  with  all  applicable  laws,   regulations  of
governmental  authority and the requirements of any securities exchange on which
shares of Twinlab Stock are traded. The Committee may require, as a condition of
the issuance and delivery of certificates  evidencing shares of Restricted Stock
pursuant to the terms hereof, that the recipient of such shares make appropriate
covenants,  agreements  and  representations,  and that such  certificates  bear
appropriate legends.

                                        3

<PAGE>

                9. Unless the Committee otherwise determines, any securities and
other property, including cash dividends, received by a Participant with respect
to a share of  Restricted  Stock  as a  result  of any  dividend,  stock  split,
recapitalization,  merger,  consolidation,  combination,  exchange  of shares or
otherwise  and for which the Grant Date occurs prior to such event but which has
not  vested  as of the date of such  event  will not vest  until  such  share of
Restricted  Stock  vests,  and shall be promptly  deposited  with the  custodian
designated by the Company to be held in custody in accordance  with Section 7(b)
hereof as though such securities and other property were part of such share.

                10.  Notices.  Any  notice  that  either  party  hereto  or  the
Committee  may be required or permitted to give to the other with respect to the
Plan or this Agreement shall be in writing,  and may be delivered  personally or
by mail, postage prepaid, addressed as follows:

        (a)  if to the Company:

                Twinlab Corporation
                150 Motor Parkway
                Hauppauge, New York 11788
                Attn:  [                 ]

        (b)  if to the Committee:

                Compensation Committee of the Board of Directors
                Twinlab Corporation
                150 Motor Parkway
                Hauppauge, New York 11788
                Attn:  [Secretary]

        (c)  if to the Participant:

                [Participant]
                [Home address]

or to such other address as the person to whom the notice is directed shall have
designated in writing to others.

                11.  Delays or  Omissions.  No delay or omission to exercise any
right,  power or remedy  accruing  to either  party  hereto  upon any  breach or
default of either party under this Agreement, shall impair any such right, power
or remedy of such party,  nor shall it be  construed  to be a waiver of any such
breach or default, or an acquiescence therein, or of or in any similar breach or
default  thereafter  occurring,  nor shall any  waiver of any  single  breach or
default  be deemed a waiver  of any  other  breach  or  default  theretofore  or
thereafter  occurring.  Any waiver,  permit,  consent or approval of any kind or
character on the part of either party of any breach or default

                                        4

<PAGE>

under  this  Agreement,  or any  waiver  on the  part  of  either  party  of any
provisions or conditions of this Agreement,  must be in a writing signed by such
party and shall be effective only to the extent  specifically  set forth in such
writing.

                12.  Integration.   This  Agreement,  and  the  other  documents
referred  to herein or  delivered  pursuant  hereto  which  form a part  hereof,
contain  the entire  understanding  of the parties  with  respect to its subject
matter.  There  are  no  restrictions,  agreements,  promises,  representations,
warranties,  covenants or undertakings with respect to the subject matter hereof
other than those expressly set forth herein. This Agreement,  including, without
limitation, the Plan, supersedes all prior agreements and understandings between
the parties with respect to its subject matter.

                13. Counterparts.  This Agreement may be executed in two or more
counterparts,  each of which shall be deemed an original, but all of which shall
constitute one and the same instrument.

                14.  Governing  Law.  This  Agreement  shall be  governed by and
construed  and  enforced in  accordance  with the laws of the State of New York,
without regard to the provisions governing conflict of laws.

                15.   Participant   Acknowledgment.   The   Participant   hereby
acknowledges  receipt of a copy of the Plan. The Participant hereby acknowledges
that all  decisions,  determinations  and  interpretations  of the  Committee in
respect of the Plan, this Agreement and the Grant shall be final and conclusive.

                IN WITNESS WHEREOF,  the Company has caused this Agreement to be
executed by its duly authorized officer, and the Participant has hereunto signed
this  Agreement on his own behalf,  thereby  representing  that he has carefully
read and  understands  this  Agreement and the Plan as of the day and year first
above written.


                                  TWINLAB CORPORATION

                                  By:_______________________________________


                                  __________________________________________
                                  [Participant]

                                        5





                                                                       EXHIBIT 5

              [LETTERHEAD OF KRAMER LEVIN NAFTALIS & FRANKEL LLP]


                                                               FACSIMILE
                                                             (212) 715-8000
                                                                 ------
                                                          WRITER'S DIRECT NUMBER

                                                              (212) 715-9100


                                             September 16, 1999

Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, D.C. 20549

Re:      Registration Statement on Form S-8

Ladies and Gentlemen:

                  We have acted as counsel  to Twinlab  Corporation,  a Delaware
corporation (the "Registrant"), in connection with the preparation and filing of
a Registration  Statement on Form S-8 (the  "Registration  Statement")  with the
Securities  and  Exchange  Commission  (the  "Commission"),  with respect to the
registration  under the  Securities  Act of 1933, as amended (the "Act"),  of an
aggregate of 65,000 shares (the  "Shares") of common stock,  par value $1.00 per
share (the "Common Stock"), to be issued pursuant to the Registrant's 1999 Stock
Incentive Plan for Outside Directors (the "Plan").

                  In connection  with the  registration  of the Shares,  we have
reviewed copies of the Registration Statement,  the Plan, the Second Amended and
Restated  Certificate of  Incorporation  and the Amended and Restated By-laws of
the  Registrant,  and such documents and records as we have deemed  necessary to
enable us to express an opinion on the matters covered hereby.

                  We  have  also  examined  and  relied  upon   representations,
statements, or certificates of public officials and officers and representatives
of the Registrant.

                  Based  upon  the  foregoing,  we are of the  opinion  that the
Shares  covered by the  Registration  Statement,  following  the granting of the
options and  restricted  stock  described in the Plan and upon  delivery of such
Shares and  payment  therefor  at the prices  and in  accordance  with the terms
stated in the Plan, will be validly issued, fully paid and non-assessable.

                  We hereby  consent to the use of this opinion as an exhibit to
the Registration  Statement.  In giving the foregoing consent, we do not thereby
admit that we are in the  category of persons  whose  consent is required  under
Section 7 of the Act or the rules and regulations of the Commission thereunder.

                  We are  delivering  this  opinion  to the  Registrant,  and no
person other than the Registrant may rely upon it.

                                       Very truly yours,

                                       /s/ Kramer Levin Naftalis & Frankel LLP
                                       ---------------------------------------
                                           Kramer Levin Naftalis & Frankel LLP





                                                                    Exhibit 23.1


                          INDEPENDENT AUDITORS' CONSENT


         We consent  to the  incorporation  by  reference  in this  Registration
Statement of Twinlab Corporation on Form S-8 of our report dated March 16, 1999,
appearing in the Annual Report on Form 10-K of Twinlab  Corporation for the year
ended December 31, 1998.


DELOITTE & TOUCHE LLP



Jericho, New York
September 10, 1999




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission